India's CDSCO has approved the first dengue vaccine, Qdenga, for individuals aged 4 to 60 after rigorous evaluation.

The vaccine has been cleared for use in individuals aged 4 to 60 years and can be administered irrespective of whether the ...

India has approved its first dengue vaccine, Qdenga, for individuals aged 4 to 60 years, providing protection against all ...

Japan's Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, ​making it the first ...

Takeda Biopharmaceuticals India Pvt Ltd. today announced that the Drug Controller General of India (DCGI) has granted market ...

India Monday approved its first dengue vaccine, marking a significant milestone in the country’s fight against one of its ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

India accounts for nearly one-third of the global dengue burden, with lakhs of people infected every year and hundreds losing ...

The San Joaquin County Mosquito and Vector Control District will not increase its benefit assessment rates for the 2026-27 fiscal year. The district's Board of Trustees ...

Victoria Ingham discusses the importance of insecticides in controlling vector-borne diseases and the ReMVeC project, which ...

New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, ...

SAEHP has announced that the British Government has confirmed a decision permitting the direct import of live horses from South Africa.